CERU - .6808 Pre-market now at 1.24/1.25 on heavy volume.
Cerulean Pharma Soars 87% - Partners with Novartis to Develop Nanoparticle-Drug Conjugates
Cerulean Announces $20 Million Firm Commitment At-The-Market Stock Purchase Agreement with Aspire Capital Fund, LLC; Initial Purchase Of 800K Shares For $1.25/Share
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.